Skip to content

Apelin-Receptor (APJ) Antagonists

A series of molecule compounds that inhibit an alternative (non-VEGF) angiogenic pathway overexpressed in a variety of cancers

Published: 27th April 2022
Apelin-Receptor (APJ) Antagonists
catalin, https://stock.adobe.com/uk/159579362, stock.adobe.com
Patents
  • US Provisional Patent Application 63/287,053 filed December 7, 2021.
IP Status
  • Provisional patent
  • Patent application submitted
Seeking
  • Development partner
  • Licensing
  • Commercial partner